89bio, Inc. (ETNB) Covered Calls

89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is BIO89-100, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also intends to develop BIO89-100 for the treatment of severe hypertriglyceridemia. 89bio, Inc. was founded in 2018 and is based in San Francisco, California.

You can sell covered calls on 89bio, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ETNB (prices last updated Thu 4:16 PM ET):

89bio, Inc. (ETNB) Stock Quote
Last	Change	Bid	Ask	Volume	P/E	Market Cap
14.96	+6.88	14.95	14.96	80.3M	-	1.2

Covered Calls For 89bio, Inc. (ETNB)
Expiration	Strike	Call Bid	Net Debit	Return If Flat	Annualized Return If Flat
Oct 17	15	0.10	14.86	0.7%	8.5%
Nov 21	15	0.15	14.81	1.0%	5.6%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls? Sign Up For A Free Trial

Top 10 Open Interest For Oct 17 Expiration				Top 5 High Yield
1.	SLV covered calls	6.	PCG covered calls	1.	QURE covered calls
2.	NVDA covered calls	7.	FXI covered calls	2.	OPEN covered calls
3.	GLD covered calls	8.	IWM covered calls	3.	BEAM covered calls
4.	IBIT covered calls	9.	SPY covered calls	4.	AEVA covered calls
5.	EEM covered calls	10.	HYG covered calls	5.	LDI covered calls

Want more examples? ETN Covered Calls | ETQ Covered Calls